One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1200/jco.2014.32.15_suppl.5556
Copy DOI Journal: Journal of Clinical Oncology |  Publication Date: May 20, 2014 |
 Citations: 3 |
Affiliation: Oslo University Hospital, Kliniken Essen-Mitte, University of Duisburg-Essen, European Institute of Oncology, University Hospital Ulm, Alexandra Hospital, Clinical Research Center Kiel, Institut Català d'Oncologia, Medical University of Vienna, Centre François Baclesse, Boehringer Ingelheim (Germany), Centre Léon Bérard, Lund University, Copenhagen University Hospital, Rigshospitalet, National Institute of Cardiovascular Diseases, Centre hospitalier régional de la Citadelle, Radboud University Nijmegen5556^ Background: N is an oral inhibitor of VEGFR, PDGFR, and FGFR. As reported earlier, in the AGO-OVAR12 trial, N compared to placebo (Pl), added to standard chemotherapy, significantly prolonged...
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
